NR

Nanthakumar Rekha

Director DIN 03620257
DIN 03620257 First appointment Sep 2011
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 2011
Shareholding value β€’β€’β€’β€’ Premium profile

About Nanthakumar Rekha

Data last updated:

Nanthakumar Rekha was a Director at Hexagon Bioresources Private Limited (from 2011) and Director at Dhruv Biotech Private Limited (from 2020).

DIN 03620257
First Appointment 01 Sep 2011
Oldest Company Age 19 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hexagon Bioresources Private Limited U01409TN2007PTC062216
Director01 Sep 20112007Strike Off
Dhruv Biotech Private Limited U37200TN2020PTC135537
Director02 Jun 20202020₹55,000 (FY 2022)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Hexagon Bioresources Private Limited
Dhruv Biotech Private Limited
Premium access

Shareholding and investment profile for Nanthakumar Rekha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nanthakumar Rekha

Nanthakumar Rekha was first appointed on 01 Sep 2011 as Director at Hexagon Bioresources Private Limited. The most recent appointment on record is 02 Jun 2020 at Dhruv Biotech Private Limited.

Nanthakumar Rekha held 2 earlier board appointments: Hexagon Bioresources Private Limited (Director, from 01 Sep 2011); Dhruv Biotech Private Limited (Director, from 02 Jun 2020).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available